Oxycodone: Difference between revisions

Line 3:

'''~~[https://en.wikipedia.org/wiki/~~Oxycodone ~~Oxycodone]~~''' (also known under brand names including '''Roxicodone''', '''w''', '''~~OxyContin~~''', '''~~Percocet~~''', '''~~Oxecta~~''', '''~~OxyIR~~''', '''~~Endone~~''', '''Oxynorm''', and '''OxyNEO''') is a semi-synthetic [[psychoactive class::opioid]] synthesized from poppy-derived thebaine. It is a narcotic analgesic within the [[chemical class::morphinan]] chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany<ref>{{Citation | title=Publication of DE296916C | url=https://patents.google.com/patent/DE296916C/en}}</ref><ref>{{cite book | vauthors=((Sneader, W.)) | date= 2005 | title=Drug discovery: a history | publisher=Wiley | isbn=9780471899792}}</ref> as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.<ref>{{cite journal | vauthors=((Kalso, E.)) | journal=Journal of Pain and Symptom Management | title=Oxycodone | volume=29 | issue=5 Suppl | pages=S47-56 | date= May 2005 | issn=0885-3924 | doi=10.1016/j.jpainsymman.2005.01.010}}</ref>

'''Oxycodone''' (also known under brand names including '''Roxicodone''', '''OxyContin''', '''Percocet''', '''Oxecta''', '''OxyIR''', '''Endone''', '''Xtampza ER, Oxaydo,''' '''Oxynorm''', and '''OxyNEO''') is a semi-synthetic [[psychoactive class::opioid]] synthesized from poppy-derived thebaine. It is a narcotic analgesic within the [[chemical class::morphinan]] chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany<ref>{{Citation | title=Publication of DE296916C | url=https://patents.google.com/patent/DE296916C/en}}</ref><ref>{{cite book | vauthors=((Sneader, W.)) | date= 2005 | title=Drug discovery: a history | publisher=Wiley | isbn=9780471899792}}</ref> as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.<ref>{{cite journal | vauthors=((Kalso, E.)) | journal=Journal of Pain and Symptom Management | title=Oxycodone | volume=29 | issue=5 Suppl | pages=S47-56 | date= May 2005 | issn=0885-3924 | doi=10.1016/j.jpainsymman.2005.01.010}}</ref>

Oxycodone is available as single-ingredient medication in immediate release and controlled release. Combination products, such as '''Percocet''', formulated with non-narcotic ingredients such as NSAIDs and paracetamol (acetaminophen) are also available.

@@ Line 3: / Line 3: @@
 {{SubstanceBox/Oxycodone}}
-'''[https://en.wikipedia.org/wiki/Oxycodone Oxycodone]''' (also known under brand names including '''Roxicodone''', '''w''', '''OxyContin''', '''Percocet''', '''Oxecta''', '''OxyIR''', '''Endone''', '''Oxynorm''', and '''OxyNEO''') is a semi-synthetic [[psychoactive class::opioid]] synthesized from poppy-derived thebaine. It is a narcotic analgesic within the [[chemical class::morphinan]] chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany<ref>{{Citation | title=Publication of DE296916C | url=https://patents.google.com/patent/DE296916C/en}}</ref><ref>{{cite book | vauthors=((Sneader, W.)) | date= 2005 | title=Drug discovery: a history | publisher=Wiley | isbn=9780471899792}}</ref> as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.<ref>{{cite journal | vauthors=((Kalso, E.)) | journal=Journal of Pain and Symptom Management | title=Oxycodone | volume=29 | issue=5 Suppl | pages=S47-56 | date= May 2005 | issn=0885-3924 | doi=10.1016/j.jpainsymman.2005.01.010}}</ref>
+'''Oxycodone''' (also known under brand names including '''Roxicodone''', '''OxyContin''', '''Percocet''', '''Oxecta''', '''OxyIR''', '''Endone''', '''Xtampza ER, Oxaydo,''' '''Oxynorm''', and '''OxyNEO''') is a semi-synthetic [[psychoactive class::opioid]] synthesized from poppy-derived thebaine. It is a narcotic analgesic within the [[chemical class::morphinan]] chemical class and is generally indicated for relief of moderate to severe pain. It was developed in 1916 in Germany<ref>{{Citation | title=Publication of DE296916C | url=https://patents.google.com/patent/DE296916C/en}}</ref><ref>{{cite book | vauthors=((Sneader, W.)) | date= 2005 | title=Drug discovery: a history | publisher=Wiley | isbn=9780471899792}}</ref> as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.<ref>{{cite journal | vauthors=((Kalso, E.)) | journal=Journal of Pain and Symptom Management | title=Oxycodone | volume=29 | issue=5 Suppl | pages=S47-56 | date= May 2005 | issn=0885-3924 | doi=10.1016/j.jpainsymman.2005.01.010}}</ref>
 Oxycodone is available as single-ingredient medication in immediate release and controlled release. Combination products, such as '''Percocet''', formulated with non-narcotic ingredients such as NSAIDs and paracetamol (acetaminophen) are also available.